help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shah, S. V.
Right arrow Articles by Eilen, S. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shah, S. V.
Right arrow Articles by Eilen, S. D.

Journal of Clinical Endocrinology & Metabolism, Vol 57, 402-409, Copyright © 1983 by Endocrine Society


ARTICLES

Chemiluminescence and superoxide anion production by leukocytes from diabetic patients

SV Shah, JD Wallin and SD Eilen

Stimulated neutrophils exhibit a burst of oxidative metabolism which results in the formation of superoxide anion and other oxygen species that participate in bacterial killing. Chemiluminescence is also produced and is a sensitive measure of oxidative metabolism and correlates well with antimicrobial activity. Since infection is an important cause of morbidity and mortality in diabetic patients we examined chemiluminescence and superoxide production by leukocytes from diabetics in the resting state and in response to a soluble (phorbol myristate acetate) and to a particulate stimulus (opsonized zymosan). No significant difference in the resting chemiluminescence was observed. However, the resting superoxide anion production by patients' leukocytes was significantly higher in autologous serum; when patients' leukocytes were placed in normal serum, a significant reduction in the resting superoxide anion production was observed. Using phorbol myristate acetate as a stimulus, leukocytes from diabetic patients had a markedly reduced chemiluminescence response [controls 388 +/- 48, n = 22, patient 220 +/- 37, peak cpm X 10(3)/10(6)P leukocytes, n = 22, (P less than 0.01)] and reduced superoxide anion response [controls 30.1 +/- 3.8, n = 16, patients 13.3 +/- 2.6 nmol/15 min/10(6)P leukocytes, n = 16 (P less than 0.001)]. Significantly reduced chemiluminescence response (P less than 0.05) and superoxide production (P less than 0.05) by leukocytes from diabetic patients were also observed using opsonized zymosan as a stimulus. No significant effects on chemiluminescence or superoxide response to phorbol myristate acetate were observed with cross-incubation studies in which patients' leukocytes were placed in normal serum or control leukocytes in patient serum. In vitro addition of insulin (25 microU; 100 microU/ml) had no significant effect on patient cell response; similarly increasing the glucose concentration from 100 mg/dl to 200 mg/dl and 400 mg/dl had no significant effect on control cell response. Glucagon in a lower concentration (200 pg/ml) had no significant effect; only at a higher concentration (400 pg/ml), it caused an inhibition of the phorbol stimulated chemiluminescence and superoxide response of control leukocytes. These results show an impaired oxidative burst by leukocytes from diabetic patients which may contribute to impaired bacterial killing and may explain, in part, the morbidity and mortality in diabetic patients suffering from infection.


This article has been cited by other articles:


Home page
J. Immunol.Home page
G. Cohen, D. Ilic, J. Raupachova, and W. H. Horl
Resistin Inhibits Essential Functions of Polymorphonuclear Leukocytes
J. Immunol., September 15, 2008; 181(6): 3761 - 3768.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
U. Kummer, J. Zobeley, J. C. Brasen, R. Fahmy, A. L. Kindzelskii, A. R. Petty, A. J. Clark, and H. R. Petty
Elevated Glucose Concentrations Promote Receptor-Independent Activation of Adherent Human Neutrophils: An Experimental and Computational Approach
Biophys. J., April 1, 2007; 92(7): 2597 - 2607.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Walrand, C. Guillet, Y. Boirie, and M.-P. Vasson
Insulin Differentially Regulates Monocyte and Polymorphonuclear Neutrophil Functions in Healthy Young and Elderly Humans
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2738 - 2748.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Karima, A. Kantarci, T. Ohira, H. Hasturk, V. L. Jones, B-H. Nam, A. Malabanan, P. C. Trackman, J. A. Badwey, and T. E. Van Dyke
Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis
J. Leukoc. Biol., October 1, 2005; 78(4): 862 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. S. Collison, R. S. Parhar, S. S. Saleh, B. F. Meyer, A. A. Kwaasi, M. M. Hammami, A. M. Schmidt, D. M. Stern, and F. A. Al-Mohanna
RAGE-mediated neutrophil dysfunction is evoked by advanced glycation end products (AGEs)
J. Leukoc. Biol., March 1, 2002; 71(3): 433 - 444.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Kashima, N. Sato, K. Sato, H. Shimizu, and M. Mori
Effect of Epalrestat, an Aldose Reductase Inhibitor, on the Generation of Oxygen-Derived Free Radicals in Neutrophils from Streptozotocin-Induced Diabetic Rats
Endocrinology, August 1, 1998; 139(8): 3404 - 3408.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society